We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Maravai LifeSciences Holdings Inc | NASDAQ:MRVI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.02 | -0.18% | 11.30 | 8.33 | 13.00 | 11.455 | 10.78 | 11.23 | 1,947,740 | 01:00:00 |
CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Delaware | 001-39725 | 85-2786970 | ||||||||||||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
10770 Wateridge Circle Suite 200 San Diego, California | 92121 | |||||||||||||
(Address of principal executive offices) | (Zip Code) | |||||||||||||
(858) 546-0004 | ||||||||||||||
(Registrant’s telephone number, including area code) | ||||||||||||||
Not Applicable (Former name or former address, if changed since last report.) | ||||||||||||||
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Class A Common Stock, $0.01 par value | MRVI | The Nasdaq Stock Market LLC | ||||||||||||
(Nasdaq Global Select Market) |
Emerging growth company | ☐ |
MARAVAI LIFESCIENCES HOLDINGS, INC. | ||||||||
Date: March 13, 2023 | By: | /s/ Kevin M. Herde | ||||||
Name: | Kevin M. Herde | |||||||
Title: | Chief Financial Officer |
1 Year Maravai LifeSciences Chart |
1 Month Maravai LifeSciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions